Your browser doesn't support javascript.
loading
Validation of SFRP1 Promoter Hypermethylation in Plasma as a Prognostic Marker for Survival and Gemcitabine Effectiveness in Patients with Stage IV Pancreatic Adenocarcinoma.
Stubbe, Benjamin Emil; Henriksen, Stine Dam; Madsen, Poul Henning; Larsen, Anders Christian; Krarup, Henrik Bygum; Pedersen, Inge Søkilde; Johansen, Martin Nygård; Thorlacius-Ussing, Ole.
Afiliación
  • Stubbe BE; Department of Gastrointestinal Surgery, Aalborg University Hospital, DK-9000 Aalborg, Denmark.
  • Henriksen SD; Clinical Cancer Research Center, Aalborg University Hospital, DK-9000 Aalborg, Denmark.
  • Madsen PH; Department of Gastrointestinal Surgery, Aalborg University Hospital, DK-9000 Aalborg, Denmark.
  • Larsen AC; Clinical Cancer Research Center, Aalborg University Hospital, DK-9000 Aalborg, Denmark.
  • Krarup HB; Department of Clinical Medicine, Aalborg University, DK-9000 Aalborg, Denmark.
  • Pedersen IS; Clinical Cancer Research Center, Aalborg University Hospital, DK-9000 Aalborg, Denmark.
  • Johansen MN; Department of Molecular Diagnostics, Aalborg University Hospital, DK-9000 Aalborg, Denmark.
  • Thorlacius-Ussing O; Department of Gastrointestinal Surgery, Aalborg University Hospital, DK-9000 Aalborg, Denmark.
Cancers (Basel) ; 13(22)2021 Nov 15.
Article en En | MEDLINE | ID: mdl-34830873
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Dinamarca
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Dinamarca